3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
23
Lymphoma, Non-Hodgkin
22
Lymphoma, Large B-Cell, Diffuse
16
Hodgkin Disease
16
Lymphoma, Mantle-Cell
13
Lymphoma, Follicular
13
Burkitt Lymphoma
9
Multiple Myeloma
7
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, B-Cell
6
Glioblastoma
6
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Leukemia
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, T-Cell
4
Gliosarcoma
4
Glioma
4
Recurrence
3
Neoplasms, Plasma Cell
3
Neoplasms
3
Leukemia, Myeloid, Acute
3
Congenital Abnormalities
3
Astrocytoma
3
Waldenstrom Macroglobulinemia
2
Primary Myelofibrosis
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Myelodysplastic Syndromes
2
Interventions
Hydroxyurea
3
Bevacizumab
3
pembrolizumab
2
Imatinib Mesylate
2
Everolimus
2
vistusertib
1
vatalanib
1
pasireotide
1
fludarabine phosphate
1
fludarabine
1
arginyllysine
1
antineoplaston AS 2-1
1
antineoplaston A10
1
aldesleukin
1
Whole Body Imaging
1
Verapamil
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiosurgery
1
Proton Therapy
1
Nivolumab
1
Modafinil
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
HDAC-42
1
Fentanyl
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Meningioma
×
Carmustine
×
Clear all
No trials found.